Treatment with 1,2,3,4-tetrahydroisoquinolone affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of γ-glutamyl transpeptidase in the dopaminergic structures of rat brain

Brain Research

Volumn 1049, Issue 2, 2005, Pages 133-146

  Lorenc Koci, Elzbieta ^a   Sokołowska, Maria ^b   Kwiecień, Inga ^b   Włodek, Lidia ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Glutamyl transpeptidase; 1,2,3,4 Tetrahydroisoquinoline; Glutathione; Nitric oxide; Parkinson's disease; S nitrosothiol

Indexed keywords

1,2,3,4 TETRAHYDROISOQUINOLONE; DOPAMINE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE DISULFIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; S NITROSOTHIOL; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; MALE; NONHUMAN; OXIDATION REDUCTION STATE; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN CHEMISTRY; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; S-NITROSOTHIOLS; TETRAHYDROISOQUINOLINES; TIME FACTORS;

EID: 22144438127     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.04.039     Document Type: Article

References (97)

1. M. Balazy, P.M. Kaminski, K. Mao, J. Tan, and M.S. Wolin S-nitroglutathione, a product of the reaction between peroxynitrite and glutathione that generates nitric oxide J. Biol. Chem. 273 1998 32009 32015
2. J.E. Barker, J.P. Bolaòos, J.M. Land, J.B. Clark, and S.J.R. Heales Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration Dev. Neurosci. 18 1996 391 396
3. M.D. Black, E.K. Matthews, and P.P.A. Humphrey The effects of a photosensitive nitric oxide donor on basal and electrically-stimulated dopamine efflux from the rat striatum in vitro Neuropharmacology 33 1994 1357 1365
4. S. Canals, M.J. Casarejos, S. de Bernardo, E. Rodriguez-Martin, and M.A. Mena Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease J. Neurochem. 79 2001 1183 1195
5. S. Canals, M.J. Casarejos, E. Rodriguez-Martin, S. de Bernardo, and M.A. Mena Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures J. Neurochem. 76 2001 56 68
6. Y. Chen, N.E. Vartiainen, W. Ying, P.H. Chan, J. Koistinaho, and R.A. Swanson Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism J. Neurochem. 77 2001 1601 1610
7. C.C. Chiueh, and P. Rauhala The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications Free Radical Res. 31 1999 641 650
8. C.C. Chiueh, G. Krishna, P. Tulsi, T. Obata, K. Lang, S.-J. Huang, and D.J. Murphy Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus Free Radical Biol. Med. 13 1992 581 583
9. T.M. Dawnson, V.L. Dawnson, and S.H. Snyder A novel neuronal messenger molecule in brain: the free radical, nitric oxide Ann. Neurol. 329 1992 297 311
10. 2 production and S-thiolation Free Radical Biol. Med. 27 1999 623 635
11. R. Drozdz, C. Parmentier, H. Hachad, P. Leroy, G. Siest, and M. Wellman γ-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system Free Radical Biol. Med. 25 1998 786 792
12. T.N. Ferraro, G.T. Golden, M. DeMattei, T.A. Hare, and R.G. Fariello Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse Neuropharmacology 25 1986 1071 1074
13. P. Foley, and P. Riederer Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease J. Neurol. 247 Suppl. 2 2000 82 94
14. M.E. Gegg, B. Beltran, S. Salas-Pino, J.P. Bolanos, J.B. Clark, S. Moncada, and S.J.R. Heales Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurons: implications for neuroprotection/neurodegeneration? J. Neurochem. 86 2003 228 237
15. D. Ghigo, P. Alessio, A. Foco, F. Bussolino, C. Costamagna, R. Heller, G. Garbarino, G.P. Pascarmana, and A. Basia Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells Am. J. Physiol. 265 1993 C728 C732
16. J.M. Gorell, C.C. Johnson, B.A. Rybicki, E.L. Peterson, and R.J. Richardson The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 1998 1346 1350
17. A.C.F. Gorren, A. Schrammel, K. Schmidt, and B. Mayer Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione Arch. Biochem. Biophys. 330 1996 219 228
18. A.J. Gow, D.G. Buerk, and H. Ischiropoulos A novel reaction mechanism for the formation of S-nitrosothiol in vivo J. Biol. Chem. 272 1997 2841 2845
19. O.W. Griffith Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine Anal. Biochem. 106 1980 207 212
20. M.J.D. Griffiths, M. Messent, R.J. MacAllister, and T.W. Evans Aminoguanidine selectively inhibits inducible nitric oxide synthase Br. J. Pharmacol. 110 1993 963 968
21. R. Guevara-Guzman, P.C. Emson, and K.M. Kendrick Modulation in vivo striatal transmitter release by nitric oxide and cyclic GMP J. Neurochem. 62 1994 807 810
22. I. Hanbauer, D. Wink, Y. Osawa, G.D. Edelman, and J.A. Galley Role of nitric oxide in NMDA-evoked release of [3H]-dopamine striatal slices NeuroReport 3 1992 409 412
23. H. Hofmann, and H.H.H.W. Schmidt Thiol dependence of nitric oxide synthase Biochemistry 34 1995 13443 13452
24. M. Ibi, H. Sawada, T. Kume, H. Katsuki, S. Kaneko, S. Shimohama, and A. Akaike Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons J. Neurochem. 73 1999 1696 1703
25. M.M. Iravani, J. Millar, and Z.L. Kruk Differential release of dopamine by nitric oxide in subregions of rat caudate putamen slices J. Neurochem. 71 1998 1969 1977
26. K. Ishiwata, Y. Koyanagi, K. Abe, K. Kawamura, K. Taguchi, T. Saitoh, J. Toda, M. Senda, and T. Sano Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D2 receptors in the mouse striatum J. Neurochem. 79 2001 868 876
27. E. Iwata-Ichikawa, Y. Kondo, I. Miyazaki, M. Asaanuma, and N. Ogawa Glial cells protect neurons against oxidative stress via transcriptional upregulation of the glutathione synthesis J. Neurochem. 72 1999 2334 2344
28. P. Jenner Oxidative mechanisms in nigral cell death in Parkinson's disease Mov. Disord. 13 1998 24 34
29. P. Jenner, D.T. Dexter, J. Sian, A.H.W. Schapira, and C.D. Marsden Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease Ann. Neurol. 32 1992 S82 S87
30. G-nitro-l-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta Biochem. Biophys. Res. Commun. 199 1994 147 154
31. D. Jourd'heuil, F.S. Laroux, A.M. Miles, D.A. Wink, and M.B. Grisham Effect of superoxide dismutase on the stability of S-nitrosothiols Arch. Biochem. Biophys. 361 1999 323 330
32. D. Jourd'heuil, F.L. Jourd'heuil, and M. Feelisch Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide J. Biol. Chem. 278 2003 15720 15726
33. V.E. Kagan, A.V. Kozlov, Y.Y. Tyurina, W. Shedova, and J.C. Yalowich Antioxidant mechanisms of nitric oxide against iron-catalysed oxidative stress in cells Antioxid. Redox Signal. 3 2001 189 202
34. M. Khan, B. Sekhon, S. Giri, M. Jatana, A.G. Gilg, K. Ayasolla, C. Elango, A.K. Singh, and I. Singh S-nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke J. Cereb. Blood Flow Metab. 25 2005 177 192
35. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem. J. 298 1994 249 258
36. M. Kohno, S. Ohta, and M. Hirobe Tetrahydroisoquinoline and 1-methyltetrahydroisoquinoline as novel endogenous amines in rat brain Biochem. Biophys. Res. Commun. 140 1986 448 454
37. P.C. Kuo, K.Y. Abe, and R.A. Schroeder Interleukin-1-induced nitric oxide production modulates glutathione synthesis in cultured rat hepatocytes Am. J. Physiol. 271 1996 C851 C862
38. F. Laszlo, S.M. Evans, and B.J.R. Whittle Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo Eur. J. Pharmacol. 272 1995 169 175
39. M.J. LaVoie, and T.G. Hastings Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss J. Neurochem. 73 1999 2546 2554
40. A.L. Levonen, J. Laakso, T. Vaskonen, E. Mervaala, H. Karppanen, and R. Lappato Downregulation of renal glutathione synthesis by systemic nitric oxide synthesis inhibition in spontaneously hypertensive rats Biochem. Pharmacol. 59 2000 441 443
41. H. Li, Z.M. Marshall, and A.R. Whorton Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels Am. J. Physiol. 276 1999 C803 C811
42. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawnson, T.M. Dawnson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Nat. Med. 5 1999 1403 1409
43. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, and J.S. Stamler A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 1993 626 632
44. E. Lorenc-Koci, M. Śmiałowska, L. Antkiewicz-Michaluk, K. Gołembiowska, K. Bajkowska, and S. Wolfarth Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats Neuroscience 95 2000 1049 1059
45. E. Lorenc-Koci, M. Sokołowska, and L. Włodek Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of γ-glutamyl transpeptidase in dopaminergic structures of rat brain Neuroscience 108 2001 413 420
46. 3H]GBR 12,935 to dopamine transporter in the nigrostriatal dopaminergic system Brain Res. 1009 2004 67 81
47. C.J. Lowenstein, and S.H. Snyder Nitric oxide, a novel biological messenger Cell 70 1992 705 707
48. S.C. Lu Regulation of glutathione synthesis Curr. Top Cell Regul. 36 2000 95 116
49. Y. Makino, S. Ohta, O. Tachikawa, and M. Hirobe Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease Life Sci. 43 1988 373 378
50. M. Marzinzig, A.K. Nussler, J. Stadler, E. Marzinzing, W. Barthlen, N.C. Nussler, H.G. Berger, S.M. Morris, and U.B. Brickner Improved methods to measure and products of nitric oxide in biological fluids: nitrite, nitrate and S-nitrosothiols Nitric Oxide 1 1997 177 189
51. M.B. Mattammal, J.H. Haring, H.D. Chung, G. Raghu, and G. Strong An endogenous dopaminergic neurotoxin: implication for Parkinson's disease Neurodegeneration 4 1995 271 281
52. B. Mayer, and B. Hemmens Biosynthesis and action of nitric oxide in mammalian cells Trends Biochem. Sci. 22 1997 477 481
53. D. Metodiewa, and C. Kośka Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview Neurotoxic Res. 1 1999 197 233
54. J. Michaluk, A. Krygowska-Wajs, B. Karolewicz, and L. Antkiewicz-Michaluk Role of noradrenergic system in the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies Pol. J. Parmacol. 54 2002 19 25
55. J. Miller, J. Selhub, and J. Joseph Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin Free Radical Biol. Med. 21 1996 241 249
56. T.P. Misko, W.M. Moore, T.P. Kasten, G.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. McDaniel, J.R.W. Williamson, and M.G. Currie Selective inhibition of the inducible nitric oxide synthase by aminoguanidine Eur. J. Pharmacol. 233 1993 119 125
57. D. Moellering, J. McAndrew, R.P. Patel, T. Cornwell, T. Lincoln, X. Cao, J.L. Messina, H.J. Forman, H. Jo, and V.M. Darley-Usmar Nitric oxide-dependent induction of glutathione synthesis through increased expression of γ-glutamylcysteine synthetase Arch. Biochem. Biophys. 358 1998 74 82
58. D. Moellering, J. McAndrew, R.P. Patel, H.J. Forman, R.T. Mulcahy, H. Jo, and V.M. Darley-Usmar The induction of GSH synthesis by nanomolar concentrations of nitric oxide in epithelial cells: a role for γ-glutamylcysteine synthetase and γ-glutamyltranspeptidase FEBS Lett. 448 1999 292 296
59. K.P. Mohanakumar, I. Hanbauer, and C.C. Chiueh Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity J. Chem. Neuroanat. 14 1998 195 205
60. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev. 43 1991 109 142
61. E.T. Morgan, V. Ullrich, A. Daiber, P. Schmidt, N. Takaya, H. Shoun, J.C. Mogiff, A. Oyekan, O.J. Hanke, W.B. Campbell, C.-S. Park, J.-S. Kang, H.-G. Yi, Y.-N. Cha, D. Mansuy, and J.-L. Boucher Cytochromes P450 and flavin monooxygenases-targets and sources of nitric oxide Drug Metab. Dispos. 29 2001 1366 1376
62. T. Nagatsu, and M. Yoshida An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions Neurosci. Lett. 87 1988 178 182
63. M. Naoi, W. Maruyama, T. Niwa, and T. Nagatsu Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin J. Neural. Transm. Suppl. 41 1994 197 205
64. C. Nathan Nitric oxide as a secretory product of mammalian cells FASEB J. 6 1992 3064 3651
65. C. Nathan, and Q.-w. Xie Regulation of biosynthesis of nitric oxide J. Biol. Chem. 269 1994 13725 13728
66. F. Niroomand, R. Rössle, A. Mülsch, and E. Böhme Under anaerobic condition, soluble guanylate cyclase is specifically stimulated by glutathione Biochem. Biophys. Res. Commun. 161 1989 75 80
67. F. Niroomand, A. Mülsch, and E. Böhme Thiol-independent stimulation of soluble guanylate cyclase by NO-containing compounds Biochem. Pharmacol. 41 1991 1777 1779
68. T. Niwa, N. Takeda, N. Kaneda, Y. Hashizume, and T. Nagatsu Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains Biochem. Biophys. Res. Commun. 144 1987 1084 1089
69. T. Niwa, H. Yoshizumi, A. Tatematsu, S. Matsuura, and T. Nagatsu Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods J. Chromat. 493 1989 347 352
70. S. Ohta, M. Kohno, Y. Makino, O. Tachikawa, and M. Hirobe Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease Biomed. Res. 8 1987 453 456
71. M. Orlowski, and A. Meister γ-Glutamyl-p-nitroanilide: a new convenient substrate for determination and study of l- and d-γ- glutamyltranspeptidase activities Biochim. Biophys. Acta 73 1963 679 681
72. A. Paolicchi, S. Dominici, L. Pieri, E. Maellaro, and A. Pompella Glutathione catabolism as a signaling mechanism Biochem. Pharmacol. 64 2002 1027 1035
73. R.K. Pearce, A. Owen, S. Daniel, P. Jenner, and C.D. Marsden Alterations in the distribution of glutathione in the substantia nigra of Parkinson's disease J. Neural Transm. 104 1997 661 667
74. E. Pileblad, T. Magnusson, and B. Fornstedt Reduction of brain glutathione by l-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum J. Neurochem. 52 1989 978 980
75. S. Przedborski, and V. Jackson-Lewis Mechanisms of MPTP toxicity Mov. Disord. 13 1998 35 38
76. S. Przedborski, V. Jackson-Lewis, R. Yokoyama, T. Shibata, V.L. Dawnson, and T.M. Dawnson Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 93 1996 4565 4571
77. P. Rauhala, A.M.-Y. Lin, and C.C. Chiueh Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress FASEB J. 12 1998 165 173
78. P. Riederer, E. Sofic, W.-D. Rausch, B. Schmidt, G.B. Reynolds, K. Jellinger, and M.B.H. Youdim Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains J. Neurochem. 52 1989 515 520
79. S.J. Robb, and J.R. Connor Nitric oxide protects astrocytes from oxidative stress Ann. N. Y. Acad. Sci. 962 2002 93 102
80. M. Salter, R.G. Knowles, and S. Moncada Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases FEBS Lett. 291 1991 145 149
81. M.A. Sharpe, S.J. Robb, and J.B. Clark Nitric oxide and Fenton/Haber-Weiss chemistry: nitric oxide is a potent antioxidant at physiological concentrations J. Neurochem. 87 2003 386 394
82. J. Sian, D.T. Dexter, A.J. Lees, S. Daniel, Y. Agid, F. Javoy-Agid, P. Jenner, and C.D. Marsden Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann. Neurol. 36 1994 348 355
83. J. Sian, D.T. Dexter, A.J. Lees, S. Daniel, Y. Agid, P. Jenner, and C.D. Marsden Glutathione-related enzymes in brain in Parkinson's disease Ann. Neurol. 36 1994 356 361
84. T.S. Smith, R.H. Swerdlow, W.D.J. Parker, and J.P.J. Bennett Reduction of MMP+-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase NeuroReport 5 1994 2600 2998
85. E. Sofic, K.W. Lange, K. Jellinger, and P. Riederer Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease Neurosci. Lett. 142 1992 128 130
86. K. Sriram, K.S. Pai, M.R. Boyd, and V. Ravindranath Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice Brain Res. 749 1997 44 52
87. 3H]dopamine from rat striatum in vitro J. Neurochem. 66 1996 131 137
88. G. Stubauer, A. Giuffrè, and P. Sarti Mechanism of S-nitrosothiol formation and degradation mediated by copper ions J. Biol. Chem. 274 1999 28128 28133
89. F. Tietze Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal. Biochem. 27 1969 502 522
90. M. Tiruchelvam, E.K. Richfield, R.B. Baggs, A.W. Tank, and D.A. Cory-Slechta The nigrostriatal dopaminergic system as a preferential target to repeated exposures to combined paraquat and maneb: implications for Parkinson's disease J. Neurosci. 20 2000 9207 9214
91. S. Toffa, G.M. Kunikowska, B.-Y. Zeng, P. Jenner, and C.D. Marsden Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration J. Neural Transm. 104 1997 67 75
92. L. Trabace, and K.M. Kendrick Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation J. Neurochem. 75 2000 1664 1674
93. A.R. West, and M.P. Galloway Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms Neurochem. Int. 33 1999 493 501
94. D.A. Wink, J.A. Cook, R. Pacelli, W. DeGreff, J. Gamson, J. Liebmann, M.C. Krishna, and J.B. Mitchell The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric formation and protection Arch. Biochem. Biophys. 331 1996 241 248
95. U. Wüllner, P.-A. Löschmann, J.B. Schulz, A. Schmid, R. Dringen, F. Eblen, L. Turski, and T. Klockgether Glutathione depletion potentiates MPTP toxicity in nigral dopaminergic neurones NeuroReport 7 1996 921 923
96. A. Van der Vliet, P.A. Chr. 't Hoen, P.S.-Y. Wong, A. Bast, and C.E. Cross Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide J. Biol. Chem. 273 1998 30255 30262
97. V.W. Yong, T.L. Perry, and A.A. Krisman Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pre-treatment Neurosci. Lett. 63 1986 56 60